Dr. Martens Reports H1 FY27 Financial Results

Dr. Martens reported H1 FY27 revenue of £290.4 million, a 9.8% decrease on a reported basis, with pairs sold falling 10.5% to 4.2 million. The company recorded an adjusted EBIT loss of £2.8 million and an adjusted pre-tax loss of £13.7 million, compared to a £9.4 million adjusted loss in the prior year. Direct-to-consumer revenue declined 12.8% on a constant currency basis, while B2B revenue fell 4.7%. Management attributed the performance to challenging market conditions, including unseasonably hot weather that impacted boot sales, and emphasized that trading in the upcoming festive weeks will be critical to the full-year outcome. The company declared an interim dividend of 0.85p and reaffirmed its medium-term guidance, focusing on its 'Levers for Growth' strategy to transition toward a consumer-first model.